REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIL.L Regulatory News (MIL)

  • There is currently no data for MIL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

1 Dec 2023 11:38

RNS Number : 4202V
Myanmar Investments Intl Ltd
01 December 2023
 

1 December 2023

Myanmar Investments International Limited

 

Results of General Meeting

 

Myanmar Investments International Limited ("MIL" or the "Company"), the AIM-quoted Myanmar focused investment company, announces that at the General Meeting held today all Resolutions were duly passed. Each of the resolutions put to the GM was voted on by way of a poll. The results of the poll for each resolution are detailed below.

 

Consequently, the last day of dealings in the Company's Ordinary Shares on AIM will be 11 December 2023 and the cancellation of admission to trading on AIM (the "Cancellation") will take effect at 7.00 a.m. on 12 December 2023.

 

Further to the announcement of 9 November 2023, the Company announces that Henrick Bodenstab has resigned as a director with immediate effect.

 

 

Resolution

For

(No. of shares)

For

(%)

Against

(No. of shares)

Against

(%)

Withheld

(No. of shares)

Withheld

(%)

1. THAT, in accordance with Rule 41 of the AIM Rules, the Cancellation of the admission to trading on AIM of the Ordinary Shares of nil par value be and is hereby approved and the Directors be authorised to take all action reasonable or necessary to effect such Cancellation.

15,303,278

100%

500

0%

0

0%

2. THAT, subject to the passing of Resolution 1 above and with effect from immediately after the Cancellation, the amended and restated Articles, a copy of which was made available to the Shareholders on the Company's website (https://www.myanmarinvestments.com/), be and are approved and upon registration with the BVI Registry of Corporate Affairs, the amended and restated Articles be adopted as the new Articles in substitution for and to the exclusion of the existing Articles.

15,303,278

100%

500

0%

0

0%

3. THAT, subject to the passing of Resolution 2 above, the registered agent of the Company be authorised to file the amended and restated Articles as required by Section 13 of the BVI Business Companies Act.

15,303,278

100%

500

0%

0

0%

4. THAT the registered agent or any Director or officer of the Company be and is authorised to take all necessary actions, execute any necessary documents and update the books and records of the Company as required in connection with the foregoing resolutions.

15,303,278

100%

500

0%

0

0%

5. THAT, to the extent that the any Director or officer of the Company has taken any actions or signed any documents or undertakings in connection with the foregoing prior to the date hereof which would have been approved if taken or signed after the date hereof, the same be and are hereby ratified, approved and confirmed.

15,302,778

100%

500

0%

0

0%

 

For further information please contact:

Nick Paris

Managing Director

Myanmar Investments International Limited +44 (0)7738 470550

nickparis@myanmarinvestments.com

 

Nominated Adviser

Philip Secrett / Jamie Barklem / Ciara Donnelly

Grant Thornton UK LLP

+44 (0) 20 7383 5100

Jay Edwin

Chief Financial Officer

Myanmar Investments International Limited

jayedwin@myanmarinvestments.com

 

 

Broker

William Marle

Cavendish Capital Markets Ltd

+44 (0) 20 7220 0500

 

For more information about MIL, please visit www.myanmarinvestments.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFVLFSLLIIV
Date   Source Headline
4th Dec 20199:04 amRNSWarrant Exercise Window - Replacement
2nd Dec 20197:00 amRNSWarrant Exercise Window
28th Nov 20197:59 amRNSInterim results to 30 September 2019
25th Nov 20198:48 amRNSAppointment of Chief Financial Officer
24th Oct 20197:02 amRNSResult of AGM
15th Oct 20194:35 pmRNSBoard changes
10th Oct 20195:54 pmRNSBoard Change
30th Sep 20192:56 pmRNSPublication of the Annual Report and Notice of AGM
25th Sep 20199:55 amRNSAudited results for the year to 31 March 2019
2nd Sep 20197:00 amRNSChange of Accounting Reference Date
19th Jun 20197:00 amRNSShareholders' rejection of unsolicited approach
18th Jun 201912:53 pmRNSRejection of unsolicited approach
13th Jun 20195:26 pmRNSHolding(s) in Company
7th Jun 20192:00 pmRNSStrategic and Business Update
25th Mar 20199:28 amRNSClarification of Investment Restrictions
21st Jan 20192:35 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSLimited Exercise of Warrants
27th Dec 20189:17 amRNSDirectorate Change
3rd Dec 20187:00 amRNSWarrant Exercise Window
26th Nov 20183:59 pmRNSInterim results to 30 September 2018
18th Oct 20188:15 amRNSResults of AGM
27th Sep 20189:42 amRNSPosting of Annual Report & Accounts/Notice of AGM
21st Sep 20187:00 amRNSAudited results for the year to 31 March 2018
21st Sep 20187:00 amRNSUpdate on Apollo Towers
4th Sep 20187:00 amRNSHoldings in Company
26th Jun 20183:43 pmRNSExercise of Warrants
22nd May 20187:00 amRNSResults of General and Warrantholders Meetings
11th May 20187:00 amRNSAppointment of Corporate Broker
30th Apr 20187:00 amRNSStrategic and Business update
23rd Apr 20187:00 amRNSMFIL secures USD 6 million loan
22nd Mar 201812:45 pmRNSExtension of warrant exercise window
15th Feb 201810:29 amRNSHolding(s) in Company
25th Jan 201812:16 pmRNSExercise of Warrants
18th Jan 20187:00 amRNSPlanned Board change
24th Nov 20177:00 amRNSInterim results to 30 Sept 2017 & strategic update
26th Oct 20171:29 pmRNSExercise of Warrants
24th Oct 20171:54 pmRNSInvestment into the Tourism sector
18th Oct 20177:47 amRNSResult of AGM
25th Sep 20177:00 amRNSAudited results for the year to 31 March 2017
26th Jun 20179:53 amRNSMFIL secures loan through Symbiotics
21st Jun 20174:31 pmRNSAdditional equity raising of US$1 million
21st Jun 201710:46 amRNSDirector/PDMR Shareholding
19th Jun 20177:00 amRNSIssue of equity raising US$6.3 million
16th Jun 20174:31 pmRNSInstitutional Subscription and PrimaryBid Offer
26th May 20172:17 pmRNSInvestment into pharmacy joint venture
3rd May 20177:00 amRNSMFIL secures second loan from Maybank
28th Apr 20174:00 pmRNSExercise of Warrants
28th Apr 20177:00 amRNSPossible equity fundraising
10th Apr 20177:00 amRNSStrategic and Trading Update
25th Jan 20173:50 pmRNSExercise of warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.